AKR7A3 suppresses tumorigenicity and chemoresistance in hepatocellular carcinoma through attenuation of ERK, c-Jun and NF-κB signaling pathways

Hepatocellular carcinoma (HCC), which accounts for 85–90% of primary liver cancer, is now the second leading cause of cancer-related mortality worldwide. Here we reported that Aldo-Keto Reductase family 7A isoform 3 (AKR7A3) is frequently down-regulated in HCC, associating with poor overall survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Chow, Raymond Kwok Kei, Tsz-Kwan Sin, Sarah, Liu, Ming, Li, Yan, Man Chan, Tim Hon, Song, Yangyang, Chen, Leilei, Lai-Wan Kwong, Dora, Guan, Xin-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663529/
https://www.ncbi.nlm.nih.gov/pubmed/29137357
http://dx.doi.org/10.18632/oncotarget.12726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663529/
https://www.ncbi.nlm.nih.gov/pubmed/29137357
http://dx.doi.org/10.18632/oncotarget.12726

Ejemplares similares